China Life(HK:02628) Ge Long Hui·2026-02-26 05:47Core Viewpoint - The performance of China Life Insurance (02628) has been weak, with the stock price dropping over 3% to a low of 31.42 HKD, indicating a potential for a technical rebound due to oversold conditions [1][3]. Technical Analysis - The stock price has fallen below the 10-day moving average (33.92 HKD) and the 30-day moving average (33.5 HKD), but remains above the 60-day moving average (30.97 HKD) [1]. - The stochastic oscillator indicates that the stock is in the oversold zone, suggesting a buy signal, while the RSI is at 48, indicating a neutral to weak position [1][3]. - Current support levels are at 31.5 HKD (first support) and 30.2 HKD (second support), with resistance levels at 34.3 HKD (first resistance) and 35.4 HKD (second resistance) [1][3]. Product Review - On February 16, China Life recorded a 2.55% increase, while UBS bull certificates (56355) and HSBC bull certificates (67560) achieved a 19% increase. UBS call options (22612) and Bank of China call options (23200) recorded a 12% increase during the same period, outperforming the underlying stock [4]. Investment Products - Notable call options include Bank of China 23200 (exercise price 35.02 HKD, 7.5x leverage) and UBS 22612 (exercise price 35.02 HKD, 7.4x leverage), both targeting the second resistance level [6]. - Put options such as JPMorgan 24962 and Morgan Stanley 25287 (exercise price 28.24 HKD, 6.2x leverage) are suitable for hedging against downside risks below the second support level [6]. - Bull certificates to consider include JPMorgan 56767 (redemption price 26.2 HKD, 4.5x leverage) and Societe Generale 60104 (redemption price 26.8 HKD, 5.2x leverage), which are positioned safely away from the current stock price [6]. - Bear certificates include Societe Generale 59427 (redemption price 38.8 HKD, 5.2x leverage) and UBS 56360 (redemption price 38 HKD, 6.1x leverage), suitable for bearish strategies [6].